Brief: Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting
18/03/2026 13:05
March 18 (Reuters) - Pliant Therapeutics Inc PLRX.O: PLIANT THERAPEUTICS ANNOUNCES UPCOMING PRESENTATION OF PHASE 1 CLINICAL TRIAL OF PLN-101095 IN PATIENTS WITH SOLID TUMORS AT THE 2026 AACR ANNUAL MEETING Source text: ID:nGNX6ndHZn Further company coverage: PLRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals